- Primary postpartum haemorrhage is identified when excessive bleeding in the first 24 hours post birth occurs.
- Active Management of Third Stage of Labor (AMTSL): A set of interventions (uterotonic use, controlled cord traction, uterine massage) to prevent PPH.
- Uterotonic Agents: Medications (e.g., oxytocin, misoprostol, ergometrine, carbetocin) that stimulate uterine contractions.
- Tranexamic Acid (TXA): An antifibrinolytic drug used to reduce bleeding in PPH.
- Uterine Atony: Failure of the uterus to contract adequately after birth, the leading cause of PPH.
- Placenta Accreta Spectrum (PAS): Abnormal adherence of the placenta to the uterine wall, increasing PPH risk.
- Balloon Tamponade: Insertion of a balloon device into the uterus to apply pressure and control bleeding.
- B-Lynch Suture: A compression suture technique applied to the uterus to control severe bleeding.
- Hemodynamic Instability: Clinical state of compromised circulation (hypotension, tachycardia) due to blood loss.
- Shock Index (SI): Ratio of heart rate to systolic blood pressure; useful for early detection of shock.
- FIGO (International Federation of Gynecology and Obstetrics): Professional body setting international guidelines on PPH management.
- WHO (World Health Organization): Provides global recommendations for PPH prevention and treatment.